Normal Serum Aminotransferase Levels and the Metabolic Syndrome: Korean National Health and Nutrition Examination Surveys
2
조회
0
다운로드
10
인용
0
참고문헌
초록
Increasing evidence suggests an association between elevated serum aminotransferase level and the metabolic syndrome. However, the significance of relatively low levels of aminotransferase in relation to the metabolic syndrome has not been fully investigated in the general population. We investigated the association between serum amiontransferase level and the metabolic syndrome using data from a nationwide survey in Korea. We measured serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels and metabolic conditions among 9771 participants aged 20 or more in the 1998 and 2001 Korean National Health and Nutrition Examination Surveys. Metabolic syndrome was defined according to NCEP-ATP III criteria with a modified waist circumference cutoff (men >90cm; women >80cm). Serum aminotransferase level, even within normal range, was associated with the metabolic syndrome independent of age, body mass index, waist circumference, smoking, and alcohol intake. Compared with the lowest level (<20IU/L), the adjusted odds ratios (95% CI) for an AST level of 20-29, 30-39, 40-49 and ≥50IU/L were 1.10 (0.85-1.42), 1.37 (1.02-1.83), 1.62 (1.08-2.43), and 2.25 (1.47-3.44) in men, and 1.18 (0.99-1.41), 1.43 (1.29-1.83), 1.71 (1.09-2.68), and 2.14 (1.20-3.80) in women, respectively. Corresponding odds ratios for ALT levels were 1.27 (0.99-1.63), 1.69 (1.28-2.23), 2.17 (1.58-2.99), and 2.65 (1.96-3.58) in men, and 1.44 (1.22-1.70), 1.65 (1.26-2.15), 2.94 (1.93-4.47), and 2.25 (1.54-3.30) in women, respectively. In conclusion, elevated serum aminotransferase levels, even in the normal to near normal range, are associated with features of the metabolic syndrome.
Abstract
Increasing evidence suggests an association between elevated serum aminotransferase level and the metabolic syndrome. However, the significance of relatively low levels of aminotransferase in relation to the metabolic syndrome has not been fully investigated in the general population. We investigated the association between serum amiontransferase level and the metabolic syndrome using data from a nationwide survey in Korea. We measured serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels and metabolic conditions among 9771 participants aged 20 or more in the 1998 and 2001 Korean National Health and Nutrition Examination Surveys. Metabolic syndrome was defined according to NCEP-ATP III criteria with a modified waist circumference cutoff (men >90cm; women >80cm). Serum aminotransferase level, even within normal range, was associated with the metabolic syndrome independent of age, body mass index, waist circumference, smoking, and alcohol intake. Compared with the lowest level (<20IU/L), the adjusted odds ratios (95% CI) for an AST level of 20-29, 30-39, 40-49 and ≥50IU/L were 1.10 (0.85-1.42), 1.37 (1.02-1.83), 1.62 (1.08-2.43), and 2.25 (1.47-3.44) in men, and 1.18 (0.99-1.41), 1.43 (1.29-1.83), 1.71 (1.09-2.68), and 2.14 (1.20-3.80) in women, respectively. Corresponding odds ratios for ALT levels were 1.27 (0.99-1.63), 1.69 (1.28-2.23), 2.17 (1.58-2.99), and 2.65 (1.96-3.58) in men, and 1.44 (1.22-1.70), 1.65 (1.26-2.15), 2.94 (1.93-4.47), and 2.25 (1.54-3.30) in women, respectively. In conclusion, elevated serum aminotransferase levels, even in the normal to near normal range, are associated with features of the metabolic syndrome.
참고문헌 (47)
- "Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance", 29, pp.495~501 (1998)
- "Nonalcoholic fatty liver disease", 346, pp.1221~1231 (2002)
- "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome", 37, pp.917~923 (2003)
- "Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors", pp.1106~10
- "Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss", 26, pp.98~106 (2000)
- "Prevalence and risk factors for hepatic steatosis in northern Italy", 132, pp.112~117 (2000)
- "NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome", 35, pp.373~379 (2002)
- "Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological and pathophysiological aspects", 35, pp.568~574 (2001)
- "Non-alcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis and liver fibrosis in the severely obese", 121, pp.91~100 (2001)
- "Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases", 18, pp.588~594 (2003)
- "Non-alcoholic fatty liver: another feature of the metabolic syndrome?", 18, pp.353~538 (1999)
- "Liver pathology and the metabolic syndrome X in severe obesity", 84, pp.1513~1517 (1999)
- "Non-alcoholic steatohepatitis, insulin resistance and metabolic syndrome; futher evidence for and etiological association", 35, pp.367~372 (2002)
- "NASH: form liver diseases to metabolic disorders and back to clinical hepatology", 35, pp.497~498 (2002)
- "Updated definitions of healthy ranges for serum alanine aminotransferase levels", 137, pp.1~9 (2002)
- "Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values", 37, pp.1286~1292 (2003)
- "Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study", 328, pp.983~986 (2004)
- "Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)", 285, pp.2486~2497 (2001)
- "The Asia-Pacific perspective: redefining obesity and its treatment" (2000), WHO[DOI]
- "Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III)", 329, pp.111~116 (2005)
- "Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study", 54, pp.3140~3147 (2005)
- "Metabolic syndrome and ALT: a community study in adult Koreans", 28, pp.1033~1038 (2004)
- "Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study", 28, pp.1757~1762 (2005)
- "Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome" (2006)
- "Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults", 13, pp.1238~1245 (2005)
- "Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy", 49, pp.289~295 (2005)
- "Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome", 28, pp.333~339 (2005)
- "Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men", 28, pp.2913~2918 (2005)
- "Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women", 54, pp.1510~1514 (2005)
- "Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents", 82, pp.1046~1051 (2005)
- "The prevalence and etiology of elevated aminotransterase levels in the United States", 98, pp.960~967 (2003)
- "Association of nonalcoholic fatty liver disease with insulin resistance", 107, pp.450~455 (1999)
- "Fatty liver-an additional and treatable feature of the insulin resistance syndrome", 92, pp.73~79 (1999)
- "Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance", 285, pp.E906~916 (2003)
- "Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study", 53, pp.2855~2860 (2004)
- "Role of hyerinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight", 13, pp.12~14 (1998)
- "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome", 50, pp.1844~1850 (2001)
- "Fatty liver in non-alcoholic nonoverweight Japanase adults: incidence and clinical characteristics.", 17, pp.1098~1105 (2002)
- "Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?", 18, pp.124~138 (2003)
- "Regional adiposity and morbidity", pp.761~811
- "The metabolic abnormalities associated with non-alcoholic fatty liver disease", 16, pp.709~731 (2002)
- "Surgical removal of visceral fat reverses hepatic insulin resistance", 48, pp.94~98 (1999)
- "Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements", pp.23~8
- "Asians are different from Caucasians and from each other in their body mass index", body fat per cent relationship, 2002, pp.3, 141~146
- "Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease", 128, pp.627~635 (2005)
- "Alanine aminotransferase in clinical practice", arch intern med 1991, pp.151~
- "The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients", 34, pp.85~91 (1999)
